# US 2015/0148358 A1 · Novel dgat2 inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0148358 A1
- Document ID: US20150148358A1
- Status: Published application
- Kind: A1
- Application number: 14/547,615
- Filed: 2014-11-19
- Published: 2015-05-28
- Earliest claimed: 2013-11-25
- Assignees: Eli Lilly and Company
- Applicants: Eli Lilly and Company
- Inventors: Manisha NAIK; Nicholas Paul CAMP
- Web page: https://patentgrep.com/patent/US20150148358A1

## CPC

- C07D 403/12: linked by a chain containing hetero atoms as chain links
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/06: Antihyperlipidemics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C07D 239/42: One nitrogen atom (nitro radicals C07D239/30)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides compounds of the Formula below: where R is H or —CH3; methods of treating patients for hypertriglyceridemia and cardiovascular disease including dyslipidemia and atherosclerosis, and processes for preparing the compounds.

## Claims

### Claim 1

A compound of the Formula:
wherein R is H or —CH3, or a pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

A compound according to claim 1 wherein R is H, or a pharmaceutically acceptable salt thereof.

### Claim 3 (depends on 1)

A compound according to claim 1 wherein R is —CH3, or a pharmaceutically acceptable salt thereof.

### Claim 4 (depends on 1)

A method of treating a patient in need of treatment for cardiovascular disease the method comprises administering to the patient an effective amount of a compound, according to claim 1, or a pharmaceutically acceptable salt thereof.

### Claim 5 (depends on 2)

A method of treating a patient in need of treatment for cardiovascular disease the method comprises administering to the patient an effective amount of a compound, according to claim 2, or a pharmaceutically acceptable salt thereof.

### Claim 6 (depends on 1)

A method of treating a patient in need of treatment for dyslipidemia, the method comprises administering to the patient an effective amount of a compound, according to claim 1, or a pharmaceutically acceptable salt thereof.

### Claim 7 (depends on 2)

A method of treating a patient in need of treatment for dyslipidemia, the method comprises administering to the patient an effective amount of a compound, according to claim 2, or a pharmaceutically acceptable salt thereof.

### Claim 8 (depends on 1)

A method of treating a patient in need of treatment for atherosclerosis, the method comprises administering to the patient an effective amount of a compound, according to claim 1, or a pharmaceutically acceptable salt thereof.

### Claim 9 (depends on 1)

A method of treating a patient in need of treatment for hypertriglyceridemia, the method comprises administering to the patient an effective amount of a compound according to claim 1, or a pharmaceutically acceptable salt thereof.

### Claim 10 (depends on 2)

A method of treating a patient in need of treatment for hypertriglyceridemia, the method comprises administering to the patient an effective amount of a compound according to claim 2, or a pharmaceutically acceptable salt thereof.

### Claim 11 (depends on 1)

A pharmaceutical composition comprising a compound according to claim 1, or a pharmaceutically acceptable salt thereof, and at least one of a pharmaceutically acceptable carrier or excipient.

### Claim 12 (depends on 2)

A pharmaceutical composition comprising a compound according to claim 2, or a pharmaceutically acceptable salt thereof, and at least one of a pharmaceutically acceptable carrier or excipient.

### Claim 13 (depends on 12)

A method of treating a patient in need for treatment for cardiovascular disease, dyslipidemia, atherosclerosis, or hypertriglyceridemia wherein the method comprises administering to the patient an effective amount of a pharmaceutical composition according to claim 12.

### Claim 14

A process for the preparation of a compound of the Formula:
wherein R is H or —CH3, and
R1 is H or a nitrogen protecting group, said method comprising:
reacting a compound of Formula 3
with a compound of Formula 4 below:

### Claim 15 (depends on 14)

The process of claim 14 wherein where R1 is a protecting group and the process further comprises removing the protecting group.
